BioCentury | Oct 13, 2016
Distillery Therapeutics

Therapeutics: Not applicable

...and safety in small and large animals. TARGET/MARKER/PATHWAY: Not applicable LICENSING STATUS: Patented; licensed to Neurona Therapeutics Inc....
BioCentury | Dec 7, 2015
Financial News

Neurona completes venture financing

Neurona Therapeutics Inc. , South San Francisco, Calif. Business: Neurology Date completed: 2015-12-01 Type: Venture financing Raised: $23.5 million Investors: The Column Group; Topspin Partners; private investors WIR Staff Neurology...
BioCentury | Dec 3, 2015
Financial News

Neurona raises $23.5M series A round

...CNS play Neurona Therapeutics Inc. (South San Francisco, Calif.) raised $23.5 million in a series A round led...
...by The Column Group. The company is developing preclinical regenerative cell-based therapies for neurological diseases. Neurona...
...Francisco , and previously received funding from the California Institute for Regenerative Medicine (CIRM) . Neurona...
BioCentury | Mar 9, 2015
Finance

Column's creations

...Svennilson said is working on overcoming resistance mechanisms in cancer. The other is CNS play Neurona Therapeutics Inc....
...Johnson & Johnson (NYSE:JNJ), New Brunswick, N.J. Merck & Co. Inc. (NYSE:MRK), Whitehouse Station, N.J. Neurona Therapeutics Inc....
BioCentury | Jun 21, 2012
Targets & Mechanisms

Reining in pain

...adult mice to treat neuropathic pain. 1 The embryonic brain cells are being developed by Neurona Therapeutics Inc....
...injury, there can be persistent activation of brain circuits, leading to hyperexcitability," said Cory Nicholas, Neurona...
...test whether iCell Neurons can behave like the UCSF team's primary MGEs in neuropathic pain. Neurona...
BioCentury | Jun 14, 2012
Distillery Therapeutics

Indication: Neurology

...Next steps include identifying ways to scale up isolation and culture of the MGE cells. Neurona Therapeutics Inc....
BioCentury | Sep 10, 2009
Targets & Mechanisms

Progenitor cell therapy for epilepsy

...epilepsy drugs, which target neuronal firing throughout the brain. The researchers have founded a company, Neurona Therapeutics Inc....
...PNAS article, along with Arnold Kriegstein, director of UCSF's Institute for Regeneration Medicine, have founded Neurona...
...Fulmer, T. SciBX 2 (35); doi:10.1038/scibx.2009.1330 Published online Sept. 10, 2009 Companies and Institutions Mentioned Neurona Therapeutics Inc....
BioCentury | Apr 2, 2009
Distillery Therapeutics

Indication: Neurology

...March 25, 2009; doi:10.1523/JNEUROSCI.5529-08.2009 Contact: Maria A. Moro, Complutense University of Madrid, Madrid, Spain e-mail: neurona@med.ucm.es BC...
Items per page:
1 - 8 of 8
BioCentury | Oct 13, 2016
Distillery Therapeutics

Therapeutics: Not applicable

...and safety in small and large animals. TARGET/MARKER/PATHWAY: Not applicable LICENSING STATUS: Patented; licensed to Neurona Therapeutics Inc....
BioCentury | Dec 7, 2015
Financial News

Neurona completes venture financing

Neurona Therapeutics Inc. , South San Francisco, Calif. Business: Neurology Date completed: 2015-12-01 Type: Venture financing Raised: $23.5 million Investors: The Column Group; Topspin Partners; private investors WIR Staff Neurology...
BioCentury | Dec 3, 2015
Financial News

Neurona raises $23.5M series A round

...CNS play Neurona Therapeutics Inc. (South San Francisco, Calif.) raised $23.5 million in a series A round led...
...by The Column Group. The company is developing preclinical regenerative cell-based therapies for neurological diseases. Neurona...
...Francisco , and previously received funding from the California Institute for Regenerative Medicine (CIRM) . Neurona...
BioCentury | Mar 9, 2015
Finance

Column's creations

...Svennilson said is working on overcoming resistance mechanisms in cancer. The other is CNS play Neurona Therapeutics Inc....
...Johnson & Johnson (NYSE:JNJ), New Brunswick, N.J. Merck & Co. Inc. (NYSE:MRK), Whitehouse Station, N.J. Neurona Therapeutics Inc....
BioCentury | Jun 21, 2012
Targets & Mechanisms

Reining in pain

...adult mice to treat neuropathic pain. 1 The embryonic brain cells are being developed by Neurona Therapeutics Inc....
...injury, there can be persistent activation of brain circuits, leading to hyperexcitability," said Cory Nicholas, Neurona...
...test whether iCell Neurons can behave like the UCSF team's primary MGEs in neuropathic pain. Neurona...
BioCentury | Jun 14, 2012
Distillery Therapeutics

Indication: Neurology

...Next steps include identifying ways to scale up isolation and culture of the MGE cells. Neurona Therapeutics Inc....
BioCentury | Sep 10, 2009
Targets & Mechanisms

Progenitor cell therapy for epilepsy

...epilepsy drugs, which target neuronal firing throughout the brain. The researchers have founded a company, Neurona Therapeutics Inc....
...PNAS article, along with Arnold Kriegstein, director of UCSF's Institute for Regeneration Medicine, have founded Neurona...
...Fulmer, T. SciBX 2 (35); doi:10.1038/scibx.2009.1330 Published online Sept. 10, 2009 Companies and Institutions Mentioned Neurona Therapeutics Inc....
BioCentury | Apr 2, 2009
Distillery Therapeutics

Indication: Neurology

...March 25, 2009; doi:10.1523/JNEUROSCI.5529-08.2009 Contact: Maria A. Moro, Complutense University of Madrid, Madrid, Spain e-mail: neurona@med.ucm.es BC...
Items per page:
1 - 8 of 8